Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Mobile Mini-Laboratory System Identifies SARS-CoV-2 Virus in 40 Minutes and Conducts 60 Tests per Day

By LabMedica International staff writers
Posted on 18 Nov 2020
A new mini-laboratory system can identify the SARS-CoV-2 virus within roughly 40 minutes and makes it possible to conduct up to 60 tests a day right on the spot where samples are taken.

Spindiag GmbH (Freiburg, Germany) is launching the coronavirus rapid test system that can identify the SARS-CoV-2 virus within roughly 40 minutes. More...
To identify the coronavirus, Spindiag has redesigned a test principle of its own conception which has already worked for antibiotic-resistant bugs. At the heart of this mobile mini-laboratory is a roughly one centimeter thick, crescent-shaped cartridge, with an integrated swab. Nurses and caregivers can use it to take smear tests, for instance from a patient’s nose or throat. They can then push the swab back into the cartridge and place it in an analytical instrument that automatically analyzes the swab and displays the test result. This makes it possible to conduct up to 60 tests a day with a mini-laboratory right on the spot where the samples are taken.

Spindiag’s test process is polymerase chain reaction (PCR)-based. Using PCR, the virus’ genome is replicated sufficiently to be identified even if there are only small quantities in a sample. Spindiag will first introduce its new coronavirus rapid test in Germany and then in all other European Union countries.

Related Links:
Spindiag GmbH


Gold Member
SARS-CoV-2 Reactive & Non-Reactive Controls
Qnostics SARS-CoV-2 Typing
Portable Electronic Pipette
Mini 96
Hemodynamic System Monitor
OptoMonitor
New
Gold Member
Hybrid Pipette
SWITCH
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The tool enables scientists to track real-time fluctuations in T cell function with unprecedented speed and precision (Photo courtesy of Shutterstock)

Luminescent Probe Measures Immune Cell Activity in Real Time

The human immune system plays a vital role in defending against disease, but its activity must be precisely monitored to ensure effective treatment in cancer therapy, autoimmune disorders, and organ transplants.... Read more

Industry

view channel
Image: The collaboration supports clinical validation and regulatory submissions of the new T1D 4-plex assay on Revvity’s GSP instrument (Photo courtesy of Revvity)

Revvity and Sanofi Collaborate on Program to Revolutionize Early Detection of Type 1 Diabetes

Type 1 diabetes (T1D) is a lifelong autoimmune condition in which the immune system destroys the pancreas’s insulin-producing beta cells, leading to dependence on insulin therapy. Early detection is critical... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.